Christian Haass
Feodor Lynen Str. 17
Munich, BY 81377, Germany
Munich, BY 81377, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 207 publications
APOEε4 attenuates early TREM2-mediated microglial responses and influences disease trajectories in dementia with Lewy bodies.
Journal: Research square
Published: August 20, 2026
Hnrnpa1 is essential for early zebrafish development and lipid metabolism: insights from a novel zebrafish knockout model.
Journal: Frontiers in cell and developmental biology
Published: January 16, 2026
Attitudes of specialist memory-clinic patients with early symptomatic Alzheimer's disease towards lecanemab: results from a multicenter survey in Europe.
Journal: Scientific reports
Published: November 15, 2025
"The DESCRIBE-ALS-FTD study: a prospective multicenter observational study of the ALS-FTD spectrum".
"The DESCRIBE-ALS-FTD study: a prospective multicenter observational study of the ALS-FTD spectrum".
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: June 09, 2025
The regulatory rollercoaster continues-EMA refuses donanemab.
Journal: Lancet (London, England)
Published: April 24, 2025
Early intervention anti-Aβ immunotherapy attenuates microglial activation without inducing exhaustion at residual plaques.
Journal: Molecular neurodegeneration
Published: March 28, 2025
Image-Derived Blood Normalization of Antibody-Based TREM2 PET in Mouse Models of Amyloidosis and Myocardial Infarction.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 07, 2025
Microglial TDP-43 mediates myelin refinement and represses Tyrobp cryptic exon inclusion in mice.
Journal: Nature neuroscience
Published: December 15, 2024
The protective PLCγ2-P522R variant mitigates Alzheimer's disease-associated pathologies by enhancing beneficial microglial functions.
Journal: Journal of neuroinflammation
Published: November 21, 2024
A reproducible three-dimensional model of human brain tissue to investigate physiological and disease-associated microglia phenotypes.
Journal: Nature neuroscience
Published: October 17, 2024
The late-onset Alzheimer's disease risk factor RHBDF2 is a modifier of microglial TREM2 proteolysis.
The late-onset Alzheimer's disease risk factor RHBDF2 is a modifier of microglial TREM2 proteolysis.
Journal: Life science alliance
Published: October 09, 2024
Last Updated: 09/26/2026